Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and Vomiting

Release Date: October 31, 2017
Expiration Date: October 31, 2018
Media: Internet - based

Activity Overview

Chemotherapy-induced nausea and vomiting (CINV) remains a significant concern for patients and care providers alike. The emergence of CINV has the potential to disrupt patient adherence to treatment protocols, reduce patient quality of life, and adversely influence other outcomes. In order to optimally manage patients who are receiving chemotherapy, clinicians need to be aware of recent changes in the classification of emetic risk with different therapy types, as well as advancements in the pharmacologic management of CINV. This educational activity has the dual objectives of updating healthcare providers on the latest advances in the management of CINV, as well as bringing greater attention to the patient perspective along the treatment continuum of care. This will be accomplished through a combination of didactic presentation (featuring audio clips of experts providing their perspectives on the state of the art in CINV management) and a patient panel discussion.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

CME/CE Activity Table of Contents

  • CINV: Scope of the Challenge
  • CINV Classification and Influence on Treatment Protocols
  • Clinical Vigilance to Minimize the Impact of CINV
  • Understanding the Evidence Supporting Pharmacologic Therapeutic Options
  • Case Scenarios
  • Overcoming Barriers to the Management of CINV
  • Patient Panel Discussion Video

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward oncologists, nurse practitioners, nurses, and physician assistants involved in the treatment and management of patients with cancer treatment-related symptoms. Pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of cancer may also participate.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:

  • Describe the impact and occurrence of CINV with commonly used chemotherapy regimens
  • Discuss emerging clinical trial data and evidence-based recommendations on supportive care strategies as they apply to the management of CINV
  • Apply clinical practice guidelines and a multidisciplinary approach to optimize the prevention and management of CINV in patients with solid tumors and hematologic malignancies
  • Incorporate skills that promote effective communication and coordination of care regarding CINV between the provider and the patient/caregiver 

Faculty, Staff, and Planners' Disclosures


Lee Schwartzberg, MD, FACP
Executive Director, West Cancer Center
Chief, Division of Hematology/Oncology
Professor of Medicine
University of Tennessee Health Science Center
Memphis, TN

Disclosure: Grant/Research Support: Helsinn, Tesaro; Consultant: Helsinn, Merck, Tesaro


Richard J. Gralla, MD, FACP
Professor of Medicine
Albert Einstein College of Medicine
Jacobi Medical Center
Bronx, NY

Disclosure: Grant/Research Support: NCI / NIH, Merck; Consultant: Merck, Helsinn, Heron, Chugai

James Natale, PharmD, BCOP
Adjunct Instructor
Clinical Pharmacy Specialist
UPMC Cancer Centers
Pittsburgh, PA

Disclosure: Speaker’s Bureau: Amgen, Merck, Eisai

Elizabeth Ott, PA-C
West Cancer Center
Memphis, TN

Disclosure: No relevant financial relationships with commercial interests to disclose.

Lauren Wiener (Patient Interviewee)
Russel Wiener (Caregiver Interviewee)

Lauren Wiener and Russel Wiener have no relevant financial relationships with commercial interests to disclose.

The following individuals have no relevant financial relationships with commercial interests:
The staff of PER®.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive, Suite 110
Cranbury, NJ 08512
Toll-Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Become a Member

Forgot Password?
Filter By